Nuclear Medicine Clinical Experience: Lutetium-177 Dotatate and I-131 Iobenguane
Tracking # 20-697051
$99999.00
Course overview
UAN: 0018-0000-20-205-H01-P & T RELEASE: 04/13/2020 EXPIRE: 04/13/2023 CREDITS: 1.5 LEARNING OBJECTIVES: 1. Provide an overview of the treatment experiences with Lutetium-177 Dotatate and I-131 Iobenguane, focusing on safety and monitoring of patients undergoing therapy NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.
Subject areas
This course counts toward the state boards and subject areas below.